| Year |
Citation |
Score |
| 2024 |
Barrett TF, Patel B, Khan SM, Mullins RDZ, Yim AKY, Pugazenthi S, Mahlokozera T, Zipfel GJ, Herzog JA, Chicoine MR, Wick CC, Durakovic N, Osbun JW, Shew M, Sweeney AD, ... ... Kim AH, et al. Single-cell multi-omic analysis of the vestibular schwannoma ecosystem uncovers a nerve injury-like state. Nature Communications. 15: 478. PMID 38216553 DOI: 10.1038/s41467-023-42762-w |
0.545 |
|
| 2023 |
Chen H, Ferguson CJ, Mitchell DC, Titus A, Paulo JA, Hwang A, Lin TH, Yano H, Gu W, Song SK, Yuede CM, Gygi SP, Bonni A, Kim AH. The Hao-Fountain syndrome protein USP7 regulates neuronal connectivity in the brain via a novel p53-independent ubiquitin signaling pathway. Biorxiv : the Preprint Server For Biology. PMID 37961719 DOI: 10.1101/2023.10.24.563880 |
0.573 |
|
| 2023 |
Terekhanova NV, Karpova A, Liang WW, Strzalkowski A, Chen S, Li Y, Southard-Smith AN, Iglesia MD, Wendl MC, Jayasinghe RG, Liu J, Song Y, Cao S, Houston A, Liu X, ... ... Kim AH, et al. Epigenetic regulation during cancer transitions across 11 tumour types. Nature. PMID 37914932 DOI: 10.1038/s41586-023-06682-5 |
0.518 |
|
| 2022 |
Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Corrigendum: Identification and management of aggressive meningiomas. Frontiers in Oncology. 12: 1107271. PMID 36582787 DOI: 10.3389/fonc.2022.1107271 |
0.743 |
|
| 2022 |
Cui Zhou D, Jayasinghe RG, Chen S, Herndon JM, Iglesia MD, Navale P, Wendl MC, Caravan W, Sato K, Storrs E, Mo CK, Liu J, Southard-Smith AN, Wu Y, Naser Al Deen N, ... ... Kim AH, et al. Spatially restricted drivers and transitional cell populations cooperate with the microenvironment in untreated and chemo-resistant pancreatic cancer. Nature Genetics. PMID 35995947 DOI: 10.1038/s41588-022-01157-1 |
0.564 |
|
| 2022 |
Mao DD, Cleary RT, Gujar A, Mahlokozera T, Kim AH. CDC20 regulates sensitivity to chemotherapy and radiation in glioblastoma stem cells. Plos One. 17: e0270251. PMID 35737702 DOI: 10.1371/journal.pone.0270251 |
0.79 |
|
| 2022 |
Wang AZ, Bowman-Kirigin JA, Desai R, Kang LI, Patel PR, Patel B, Khan SM, Bender D, Marlin MC, Liu J, Osbun JW, Leuthardt EC, Chicoine MR, Dacey RG, Zipfel GJ, ... Kim AH, et al. Single-cell profiling of human dura and meningioma reveals cellular meningeal landscape and insights into meningioma immune response. Genome Medicine. 14: 49. PMID 35534852 DOI: 10.1186/s13073-022-01051-9 |
0.73 |
|
| 2022 |
Patel B, Desai R, Pugazenthi S, Butt OH, Huang J, Kim AH. Identification and Management of Aggressive Meningiomas. Frontiers in Oncology. 12: 851758. PMID 35402234 DOI: 10.3389/fonc.2022.851758 |
0.772 |
|
| 2022 |
Yang PH, Tao Y, Luo J, Paturu M, Lu HC, Ramkissoon S, Heusel JW, Leuthardt EC, Chicoine MR, Dowling JL, Dunn GP, Duncavage E, Dahiya S, Chattherjee AR, Kim AH. Multivariate analysis of associations between clinical sequencing and outcome in glioblastoma. Neuro-Oncology Advances. 4: vdac002. PMID 35156038 DOI: 10.1093/noajnl/vdac002 |
0.774 |
|
| 2021 |
Mahlokozera T, Patel B, Chen H, Desouza P, Qu X, Mao DD, Hafez D, Yang W, Taiwo R, Paturu M, Salehi A, Gujar AD, Dunn GP, Mosammaparast N, Petti AA, ... ... Kim AH, et al. Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma. Nature Communications. 12: 6321. PMID 34732716 DOI: 10.1038/s41467-021-26653-6 |
0.713 |
|
| 2021 |
Smith HJ, Durakovic N, Patel B, Varagur K, Gupta S, Khan AM, Kallogjeri D, Kim AH, Piccirillo JF, Buchman CA. Clinical Staging to Estimate the Probability of Severe Postoperative Complications in Patients With Vestibular Schwannoma. Jama Otolaryngology-- Head & Neck Surgery. PMID 34617972 DOI: 10.1001/jamaoto.2021.2626 |
0.732 |
|
| 2021 |
DeSouza PA, Qu X, Chen H, Patel B, Maher CA, Kim AH. Long, Noncoding RNA Dysregulation in Glioblastoma. Cancers. 13. PMID 33807183 DOI: 10.3390/cancers13071604 |
0.768 |
|
| 2021 |
Galdieri L, Jash A, Malkova O, Mao DD, DeSouza PA, Chu YE, Salter A, Campian JL, Naegle KM, Brennan CW, Wakimoto H, Oh ST, Kim AH, Chheda MG. Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry. Jci Insight. PMID 33400685 DOI: 10.1172/jci.insight.128456 |
0.781 |
|
| 2020 |
Shah AS, Yahanda AT, Sylvester PT, Evans J, Dunn GP, Jensen RL, Honeycutt J, Cahill DP, Sutherland GR, Oswood M, Shah M, Abram SR, Rich KM, Dowling JL, Leuthardt EC, ... ... Kim AH, et al. Using Histopathology to Assess the Reliability of Intraoperative Magnetic Resonance Imaging in Guiding Additional Brain Tumor Resection: A Multicenter Study. Neurosurgery. PMID 32803226 DOI: 10.1093/Neuros/Nyaa338 |
0.31 |
|
| 2020 |
Yahanda AT, Patel B, Shah AS, Cahill DP, Sutherland G, Honeycutt J, Jensen RL, Rich KM, Dowling JL, Limbrick DD, Dacey RG, Kim AH, Leuthardt EC, Dunn GP, Zipfel GJ, et al. Impact of Intraoperative Magnetic Resonance Imaging and Other Factors on Surgical Outcomes for Newly Diagnosed Grade II Astrocytomas and Oligodendrogliomas: A Multicenter Study. Neurosurgery. PMID 32717067 DOI: 10.1093/Neuros/Nyaa320 |
0.728 |
|
| 2020 |
Patel B, Yang PH, Kim AH. The effect of thermal therapy on the blood-brain barrier and blood-tumor barrier. International Journal of Hyperthermia : the Official Journal of European Society For Hyperthermic Oncology, North American Hyperthermia Group. 37: 35-43. PMID 32672118 DOI: 10.1080/02656736.2020.1783461 |
0.764 |
|
| 2020 |
Salehi A, Paturu MR, Patel B, Cain MD, Mahlokozera T, Yang AB, Lin TH, Leuthardt EC, Yano H, Song SK, Klein RS, Schmidt R, Kim AH. Therapeutic enhancement of blood-brain and blood-tumor barriers permeability by laser interstitial thermal therapy. Neuro-Oncology Advances. 2: vdaa071. PMID 32666049 DOI: 10.1093/noajnl/vdaa071 |
0.748 |
|
| 2020 |
Patel B, Taiwo R, Kim AH, Dunn GP. , a promoter of CNS malignancies. Neuro-Oncology Advances. 2: vdaa025. PMID 32226942 DOI: 10.1093/noajnl/vdaa025 |
0.778 |
|
| 2020 |
Patel B, Kim AH. Laser Interstitial Thermal Therapy. Missouri Medicine. 117: 50-55. PMID 32158050 |
0.727 |
|
| 2019 |
Yahanda AT, Patel B, Sutherland G, Honeycutt J, Jensen RL, Smyth MD, Limbrick DD, Dacey RG, Dowling JL, Dunn GP, Kim AH, Leuthardt EC, Rich KM, Zipfel GJ, Leonard JR, et al. A multi-institutional analysis of factors influencing surgical outcomes for patients with newly diagnosed grade I gliomas. World Neurosurgery. PMID 31901497 DOI: 10.1016/J.Wneu.2019.12.156 |
0.74 |
|
| 2019 |
Han RH, Dunn GP, Chheda MG, Kim AH. The impact of systemic precision medicine and immunotherapy treatments on brain metastases. Oncotarget. 10: 6739-6753. PMID 31803366 DOI: 10.18632/Oncotarget.27328 |
0.311 |
|
| 2019 |
Yang W, Warrington NM, Taylor SJ, Whitmire P, Carrasco E, Singleton KW, Wu N, Lathia JD, Berens ME, Kim AH, Barnholtz-Sloan JS, Swanson KR, Luo J, Rubin JB. Sex differences in GBM revealed by analysis of patient imaging, transcriptome, and survival data. Science Translational Medicine. 11. PMID 30602536 DOI: 10.1126/Scitranslmed.Aao5253 |
0.307 |
|
| 2019 |
Salehi A, Paturu M, Caine M, Klein R, Kim AH. Laser Therapy Enhances Blood-Brain Barrier and Blood-Tumor Barrier Permeability in a Mouse Model of Glioblastoma Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_635 |
0.331 |
|
| 2019 |
Mahlokozera T, Paturu M, Hafez D, Mao D, Kim AH. The TRIM26-SOX2 Ubiquitin Signaling Axis Regulates the Maintenance and Tumorigenicity of Glioblastoma Stem-like Cells Neurosurgery. 66. DOI: 10.1093/Neuros/Nyz310_215 |
0.42 |
|
| 2019 |
Paturu M, Salehi A, Caine M, Mahlokozera T, Yano H, Leuthardt E, Klein R, Schmidt R, Kim A. EXTH-35. LASER INTERSTITIAL THERMAL THERAPY INCREASES BLOOD-BRAIN BARRIER AND BLOOD-TUMOR BARRIER PERMEABILITY IN A MOUSE MODEL OF GLIOBLASTOMA Neuro-Oncology. 21: vi89-vi89. DOI: 10.1093/Neuonc/Noz175.367 |
0.363 |
|
| 2019 |
Tran D, Campian J, Shimony J, Kim A, Ansstas G, Leuthardt E. SCIDOT-43. FINAL DATA ANALYSIS OF A PILOT STUDY TESTING THE EFFICACY OF USING LASER INTERSTITIAL THERMAL THERAPY (LITT) TO INDUCE TEMPORARY DISRUPTION OF THE PERITUMORAL BLOOD BRAIN BARRIER (BBB) TO IMPROVE EFFECTIVENESS OF BBB-IMPERMEANT CHEMOTHERAPY IN RECURRENT GLIOBLASTOMA Neuro-Oncology. 21: vi280-vi281. DOI: 10.1093/Neuonc/Noz175.1179 |
0.317 |
|
| 2019 |
Campian J, Ghiaseddin A, Rahman M, Huang J, Ansstas G, Kim A, Leuthardt E, Tran D. ATIM-45. LONG TERM FOLLOW-UP OF A PHASE I/II STUDY TESTING THE TOXICITIES AND EFFICACY OF PEMBROLIZUMAB IN COMBINATION WITH MRI-GUIDED LASER INTERSTITIAL THERMAL THERAPY (LITT) IN RECURRENT MALIGNANT GLIOMAS Neuro-Oncology. 21: vi11-vi11. DOI: 10.1093/Neuonc/Noz175.043 |
0.339 |
|
| 2018 |
Taiwo R, Mahlokozera T, Kim AH. Erratum to stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool. Stem Cell Investigation. 5: 48. PMID 30701183 DOI: 10.21037/Sci.2018.11.06 |
0.771 |
|
| 2018 |
Salehi A, Kamath AA, Leuthardt EC, Kim AH. Management of Intracranial Metastatic Disease With Laser Interstitial Thermal Therapy. Frontiers in Oncology. 8: 499. PMID 30430083 DOI: 10.3389/Fonc.2018.00499 |
0.765 |
|
| 2018 |
Taiwo R, Mahlokozera T, Kim AH. Stem nourished by branches: glioblastomas co-opt classic neurotrophic factor signaling to maintain stem-like cell pool. Stem Cell Investigation. 5: 22. PMID 30148155 DOI: 10.21037/sci.2018.07.01 |
0.773 |
|
| 2018 |
Gabani P, Fischer-Valuck BW, Johanns TM, Hernandez-Aya LF, Keller JW, Rich KM, Kim AH, Dunn GP, Robinson CG, Chicoine MR, Huang J, Abraham CD. Stereotactic radiosurgery and immunotherapy in melanoma brain metastases: Patterns of care and treatment outcomes. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 29960685 DOI: 10.1016/J.Radonc.2018.06.017 |
0.312 |
|
| 2018 |
Pan Y, Zhu Y, Yang W, Tycksen E, Liu S, Palucki J, Zhu L, Sasaki Y, Sharma MK, Kim AH, Zhang B, Yano H. The role of Twist1 in mutant huntingtin-induced transcriptional alterations and neurotoxicity. The Journal of Biological Chemistry. PMID 29891550 DOI: 10.1074/Jbc.Ra117.001211 |
0.308 |
|
| 2018 |
Gujar AD, Mao DD, Finlay JB, Kim AH. Establishing Primary Human Glioblastoma Adherent Cultures from Operative Specimens. Methods in Molecular Biology (Clifton, N.J.). 1741: 53-62. PMID 29392689 DOI: 10.1007/978-1-4939-7659-1_3 |
0.739 |
|
| 2018 |
Huang J, Campian JL, Gujar AD, Tsien C, Ansstas G, Tran DD, DeWees TA, Lockhart AC, Kim AH. Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma. Journal of Neuro-Oncology. PMID 29374809 DOI: 10.1007/S11060-018-2775-Y |
0.707 |
|
| 2018 |
Mahlokozera T, Taiwo R, Mao D, Salehi A, Gujar A, Kim A. STEM-07. NON-CANONICAL REGULATION OF SOX2 BY THE TRIM26 E3 UBIQUITIN LIGASE IN GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 20: vi245-vi245. DOI: 10.1093/Neuonc/Noy148.1014 |
0.742 |
|
| 2017 |
Barrow AD, Edeling MA, Trifonov V, Luo J, Goyal P, Bohl B, Bando JK, Kim AH, Walker J, Andahazy M, Bugatti M, Melocchi L, Vermi W, Fremont DH, Cox S, et al. Natural Killer Cells Control Tumor Growth by Sensing a Growth Factor. Cell. PMID 29275861 DOI: 10.1016/J.Cell.2017.11.037 |
0.344 |
|
| 2017 |
Mahlokozera T, Vellimana AK, Li T, Mao DD, Zohny ZS, Kim DH, Tran DD, Marcus DS, Fouke SJ, Campian JL, Dunn GP, Miller CA, Kim AH. Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastomas. Neuro-Oncology. PMID 29244145 DOI: 10.1093/Neuonc/Nox232 |
0.763 |
|
| 2017 |
Wu M, Guan J, Li C, Gunter S, Nusrat L, Ng S, Dhand K, Morshead C, Kim A, Das S. Aberrantly activated Cox-2 and Wnt signaling interact to maintain cancer stem cells in glioblastoma. Oncotarget. 8: 82217-82230. PMID 29137258 DOI: 10.18632/Oncotarget.19283 |
0.389 |
|
| 2017 |
Slat EA, Sponagel J, Marpegan L, Simon T, Kfoury N, Kim A, Binz A, Herzog ED, Rubin JB. Cell-intrinsic, Bmal1-dependent Circadian Regulation of Temozolomide Sensitivity in Glioblastoma. Journal of Biological Rhythms. 32: 121-129. PMID 28470120 DOI: 10.1177/0748730417696788 |
0.345 |
|
| 2017 |
Taiwo R, Mao D, Mahlokozera T, Kim A. STEM-19. THE TCF12 TRANSCRIPTION FACTOR CONTROLS PRONEURAL GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 19: vi230-vi230. DOI: 10.1093/Neuonc/Nox168.935 |
0.336 |
|
| 2017 |
Tran D, Leuthardt E, Shimony J, Kim A, Ansstas G, Campian J. ACTR-82. LASER INTERSTITIAL THERMAL THERAPY (LITT) OF RECURRENT GLIOBLASTOMA (GBM) INDUCES TEMPORARY DISRUPTION OF THE PERITUMORAL BLOOD BRAIN BARRIER (BBB) AND MAY IMPROVE EFFICACY OF CHEMOTHERAPY WITH POOR CNS PENETRATION Neuro-Oncology. 19: vi18-vi18. DOI: 10.1093/Neuonc/Nox168.068 |
0.308 |
|
| 2017 |
Huang J, Campian J, Gujar A, Tsien C, Ansstas G, Tran D, Dewees T, Kim A, Lockhart AC. Actr-21. Updated Results Of A Phase I Dose-Escalation, Dose-Expansion Study Of Disulfiram And Adjuvant Temozolomide For Newly Diagnosed Glioblastoma Neuro-Oncology. 19. DOI: 10.1093/Neuonc/Nox168.016 |
0.698 |
|
| 2016 |
Gujar AD, Le S, Mao DD, Dadey DY, Turski A, Sasaki Y, Aum D, Luo J, Dahiya S, Yuan L, Rich KM, Milbrandt J, Hallahan DE, Yano H, Tran DD, ... Kim AH, et al. An NAD+-dependent transcriptional program governs self-renewal and radiation resistance in glioblastoma. Proceedings of the National Academy of Sciences of the United States of America. PMID 27930300 DOI: 10.1073/Pnas.1610921114 |
0.755 |
|
| 2016 |
Gujar AD, Yano H, Kim AH. The CDC20-APC/SOX2 signaling axis: An achilles' heel for glioblastoma. Molecular & Cellular Oncology. 3: e1075644. PMID 27314081 DOI: 10.1080/23723556.2015.1075644 |
0.759 |
|
| 2016 |
Huang J, Campian JL, Gujar AD, Tran DD, Lockhart AC, DeWees TA, Tsien CI, Kim AH. A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy. Journal of Neuro-Oncology. PMID 26966095 DOI: 10.1007/S11060-016-2104-2 |
0.714 |
|
| 2016 |
Johanns TM, Fu Y, Kobayashi DK, Mei Y, Dunn IF, Mao DD, Kim AH, Dunn GP. High incidence of TERT mutation in brain tumor cell lines. Brain Tumor Pathology. PMID 26960334 DOI: 10.1007/S10014-016-0257-5 |
0.325 |
|
| 2016 |
Leuthardt EC, Duan C, Kim MJ, Campian JL, Kim AH, Miller-Thomas MM, Shimony JS, Tran DD. Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier. Plos One. 11: e0148613. PMID 26910903 DOI: 10.1371/Journal.Pone.0148613 |
0.323 |
|
| 2016 |
Kang SK, Murphy RK, Hwang SW, Lee SM, Harburg DV, Krueger NA, Shin J, Gamble P, Cheng H, Yu S, Liu Z, McCall JG, Stephen M, Ying H, Kim J, ... ... Kim AH, et al. Bioresorbable silicon electronic sensors for the brain. Nature. PMID 26779949 DOI: 10.1038/Nature16492 |
0.705 |
|
| 2016 |
Gujar A, Turski A, Le S, Mao D, Dadey D, Aum D, Luo J, Hallahan D, Tran D, Yano H, Kim A. CSIG-20. IDENTIFICATION OF A NAMPT-E2F2-ID1 SIGNALING AXIS IN GLIOBLASTOMA Neuro-Oncology. 18: vi45-vi45. DOI: 10.1093/Neuonc/Now212.181 |
0.712 |
|
| 2015 |
Sengupta R, Barone A, Marasa J, Taylor S, Jackson E, Warrington NM, Rao S, Kim AH, Leonard JR, Piwnica-Worms D, Rubin JB. Novel chemical library screen identifies naturally occurring plant products that specifically disrupt glioblastoma-endothelial cell interactions. Oncotarget. 6: 18282-92. PMID 26286961 DOI: 10.18632/Oncotarget.4957 |
0.356 |
|
| 2015 |
Mao DD, Gujar AD, Mahlokozera T, Chen I, Pan Y, Luo J, Brost T, Thompson EA, Turski A, Leuthardt EC, Dunn GP, Chicoine MR, Rich KM, Dowling JL, Zipfel GJ, ... ... Kim AH, et al. A CDC20-APC/SOX2 Signaling Axis Regulates Human Glioblastoma Stem-like Cells. Cell Reports. 11: 1809-21. PMID 26074073 DOI: 10.1016/J.Celrep.2015.05.027 |
0.811 |
|
| 2015 |
Huang J, DeWees TA, Badiyan SN, Speirs CK, Mullen DF, Fergus S, Tran DD, Linette G, Campian JL, Chicoine MR, Kim AH, Dunn G, Simpson JR, Robinson CG. Clinical and Dosimetric Predictors of Acute Severe Lymphopenia During Radiation Therapy and Concurrent Temozolomide for High-Grade Glioma. International Journal of Radiation Oncology, Biology, Physics. 92: 1000-7. PMID 26025775 DOI: 10.1016/J.Ijrobp.2015.04.005 |
0.304 |
|
| 2015 |
Speirs CK, Simpson JR, Robinson CG, DeWees TA, Tran DD, Linette G, Chicoine MR, Dacey RG, Rich KM, Dowling JL, Leuthardt EC, Zipfel GJ, Kim AH, Huang J. Impact of 1p/19q codeletion and histology on outcomes of anaplastic gliomas treated with radiation therapy and temozolomide. International Journal of Radiation Oncology, Biology, Physics. 91: 268-76. PMID 25636755 DOI: 10.1016/J.Ijrobp.2014.10.027 |
0.308 |
|
| 2015 |
Gujar A, Mahlokozera T, Mao D, Pan Y, Yano H, Kim A. STEM-11MECHANISMS OF CDC20-ANAPHASE-PROMOTING COMPLEX ACTION IN HUMAN GLIOBLASTOMA STEM-LIKE CELLS Neuro-Oncology. 17: v210.3-v210. DOI: 10.1093/Neuonc/Nov234.11 |
0.766 |
|
| 2015 |
Huang J, Campian J, Gujar A, Tran D, Lockhart AC, DeWees T, Tsien C, Kim A. ATNT-11A PHASE I PHARMACODYNAMIC STUDY OF DISULFIRAM AND TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA AFTER RADIATION THERAPY AND CONCURRENT TEMOZOLOMIDE Neuro-Oncology. 17: v12.3-v12. DOI: 10.1093/Neuonc/Nov205.11 |
0.718 |
|
| 2014 |
Aum DJ, Kim DH, Beaumont TL, Leuthardt EC, Dunn GP, Kim AH. Molecular and cellular heterogeneity: the hallmark of glioblastoma. Neurosurgical Focus. 37: E11. PMID 25434380 DOI: 10.3171/2014.9.Focus14521 |
0.373 |
|
| 2014 |
Brooks MD, Jackson E, Warrington NM, Luo J, Forys JT, Taylor S, Mao DD, Leonard JR, Kim AH, Piwnica-Worms D, Mitra RD, Rubin JB. PDE7B is a novel, prognostically significant mediator of glioblastoma growth whose expression is regulated by endothelial cells. Plos One. 9: e107397. PMID 25203500 DOI: 10.1371/Journal.Pone.0107397 |
0.377 |
|
| 2014 |
Garsa AA, Badiyan SN, DeWees T, Simpson JR, Huang J, Drzymala RE, Barani IJ, Dowling JL, Rich KM, Chicoine MR, Kim AH, Leuthardt EC, Robinson CG. Predictors of individual tumor local control after stereotactic radiosurgery for non-small cell lung cancer brain metastases. International Journal of Radiation Oncology, Biology, Physics. 90: 407-13. PMID 25084610 DOI: 10.1016/J.Ijrobp.2014.05.047 |
0.308 |
|
| 2014 |
Kim AH, Thompson EA, Governale LS, Santa C, Cahll K, Kieran MW, Chi SN, Ullrich NJ, Scott RM, Goumnerova LC. Recurrence after gross-total resection of low-grade pediatric brain tumors: the frequency and timing of postoperative imaging. Journal of Neurosurgery. Pediatrics. 14: 356-64. PMID 25062303 DOI: 10.3171/2014.6.Peds1321 |
0.313 |
|
| 2014 |
Lin A, Liu J, Huang J, Robinson C, Simpson J, Chicoine M, Dacey R, Kim A, Rich K, Leuthardt E, Linette G, Miller-Thomas M, Schmidt R, Dahiya S, Tran D. BI-19 * PSEUDOPROGRESSION IN OLIGODENDROGLIOMAS AND MIXED OLIGOASTROCYTOMAS IS ASSOCIATED WITH POOR PROGNOSIS Neuro-Oncology. 16: v27-v27. DOI: 10.1093/Neuonc/Nou239.19 |
0.32 |
|
| 2013 |
Puram SV, Kim AH, Park HY, Anckar J, Bonni A. The ubiquitin receptor S5a/Rpn10 links centrosomal proteasomes with dendrite development in the mammalian brain. Cell Reports. 4: 19-30. PMID 23831032 DOI: 10.1016/J.Celrep.2013.06.006 |
0.71 |
|
| 2011 |
Puram SV, Riccio A, Koirala S, Ikeuchi Y, Kim AH, Corfas G, Bonni A. A TRPC5-regulated calcium signaling pathway controls dendrite patterning in the mammalian brain. Genes & Development. 25: 2659-73. PMID 22135323 DOI: 10.1101/Gad.174060.111 |
0.755 |
|
| 2011 |
Puram SV, Kim AH, Ikeuchi Y, Wilson-Grady JT, Merdes A, Gygi SP, Bonni A. A CaMKIIβ signaling pathway at the centrosome regulates dendrite patterning in the brain. Nature Neuroscience. 14: 973-83. PMID 21725312 DOI: 10.1038/Nn.2857 |
0.767 |
|
| 2010 |
Puram SV, Kim AH, Bonni A. An old dog learns new tricks: a novel function for Cdc20-APC in dendrite morphogenesis in neurons. Cell Cycle (Georgetown, Tex.). 9: 482-5. PMID 20195072 DOI: 10.4161/Cc.9.3.10558 |
0.707 |
|
| 2010 |
Yang Y, Kim AH, Bonni A. The dynamic ubiquitin ligase duo: Cdh1-APC and Cdc20-APC regulate neuronal morphogenesis and connectivity. Current Opinion in Neurobiology. 20: 92-9. PMID 20060286 DOI: 10.1016/J.Conb.2009.12.004 |
0.636 |
|
| 2009 |
Yang Y, Kim AH, Yamada T, Wu B, Bilimoria PM, Ikeuchi Y, de la Iglesia N, Shen J, Bonni A. A Cdc20-APC ubiquitin signaling pathway regulates presynaptic differentiation. Science (New York, N.Y.). 326: 575-8. PMID 19900895 DOI: 10.1126/Science.1177087 |
0.786 |
|
| 2009 |
Nagahara AH, Merrill DA, Coppola G, Tsukada S, Schroeder BE, Shaked GM, Wang L, Blesch A, Kim A, Conner JM, Rockenstein E, Chao MV, Koo EH, Geschwind D, Masliah E, et al. Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease. Nature Medicine. 15: 331-7. PMID 19198615 DOI: 10.1038/Nm.1912 |
0.504 |
|
| 2009 |
Kim AH, Puram SV, Bilimoria PM, Ikeuchi Y, Keough S, Wong M, Rowitch D, Bonni A. A centrosomal Cdc20-APC pathway controls dendrite morphogenesis in postmitotic neurons. Cell. 136: 322-36. PMID 19167333 DOI: 10.1016/J.Cell.2008.11.050 |
0.773 |
|
| 2008 |
Kim AH, Bonni A. Cdk1-FOXO1: a mitotic signal takes center stage in post-mitotic neurons. Cell Cycle (Georgetown, Tex.). 7: 3819-22. PMID 19124971 DOI: 10.4161/Cc.7.24.7215 |
0.622 |
|
| 2007 |
Kim AH, Bonni A. Thinking within the D box: initial identification of Cdh1-APC substrates in the nervous system. Molecular and Cellular Neurosciences. 34: 281-7. PMID 17223572 DOI: 10.1016/J.Mcn.2006.11.019 |
0.598 |
|
| 2003 |
Kim AH, Sasaki T, Chao MV. JNK-interacting protein 1 promotes Akt1 activation. The Journal of Biological Chemistry. 278: 29830-6. PMID 12783873 DOI: 10.1074/Jbc.M305349200 |
0.515 |
|
| 2002 |
Kim AH, Yano H, Cho H, Meyer D, Monks B, Margolis B, Birnbaum MJ, Chao MV. Akt1 regulates a JNK scaffold during excitotoxic apoptosis. Neuron. 35: 697-709. PMID 12194869 DOI: 10.1016/S0896-6273(02)00821-8 |
0.515 |
|
| 2002 |
Lee FS, Rajagopal R, Kim AH, Chang PC, Chao MV. Activation of Trk neurotrophin receptor signaling by pituitary adenylate cyclase-activating polypeptides. The Journal of Biological Chemistry. 277: 9096-102. PMID 11784714 DOI: 10.1074/Jbc.M107421200 |
0.612 |
|
| 2001 |
Lee FS, Kim AH, Khursigara G, Chao MV. The uniqueness of being a neurotrophin receptor. Current Opinion in Neurobiology. 11: 281-6. PMID 11399425 DOI: 10.1016/S0959-4388(00)00209-9 |
0.764 |
|
| 2001 |
Kim AH, Khursigara G, Sun X, Franke TF, Chao MV. Akt phosphorylates and negatively regulates apoptosis signal-regulating kinase 1. Molecular and Cellular Biology. 21: 893-901. PMID 11154276 DOI: 10.1128/Mcb.21.3.893-901.2001 |
0.759 |
|
| 1999 |
Kong H, Kim AH, Orlinick JR, Chao MV. A comparison of the cytoplasmic domains of the Fas receptor and the p75 neurotrophin receptor. Cell Death and Differentiation. 6: 1133-42. PMID 10578183 DOI: 10.1038/Sj.Cdd.4400587 |
0.473 |
|
| Show low-probability matches. |